UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2012-03, Vol.54 (6), p.755-771

2012

Volltextzugriff (PDF)

Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.734-744

2013

Volltextzugriff (PDF)

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3315-3320

2008

Volltextzugriff (PDF)

Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents

Antimicrobial agents and chemotherapy, 2019-05, Vol.63 (5)

2019

Volltextzugriff (PDF)

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1606-1610

2011

Volltextzugriff (PDF)

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Clinical infectious diseases, 2007-02, Vol.44 (3), p.357-363

2007

Volltextzugriff (PDF)

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.4094-4102

2014

Volltextzugriff (PDF)

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4087-4094

2012

Volltextzugriff (PDF)

Meropenem Penetration into Epithelial Lining Fluid in Mice and Humans and Delineation of Exposure Targets

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3406-3412

2011

Volltextzugriff (PDF)

Identification of Optimal Renal Dosage Adjustments for Traditional and Extended-Infusion Piperacillin-Tazobactam Dosing Regimens in Hospitalized Patients

Antimicrobial Agents and Chemotherapy, 2010-01, Vol.54 (1), p.460-465

2010

Volltextzugriff (PDF)

Telavancin Pharmacokinetics and Pharmacodynamics in Patients with Complicated Skin and Skin Structure Infections and Various Degrees of Renal Function

Antimicrobial Agents and Chemotherapy, 2012-04, Vol.56 (4), p.2062-2066

2012

Volltextzugriff (PDF)

A Systematic Review of the Methods Used to Assess the Association between Appropriate Antibiotic Therapy and Mortality in Bacteremic Patients

Clinical infectious diseases, 2007-08, Vol.45 (3), p.329-337

2007

Volltextzugriff (PDF)

Comparative Evaluation of Serotonin Toxicity among Veterans Affairs Patients Receiving Linezolid and Vancomycin

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.5901-5911

2013

Volltextzugriff (PDF)

Correlation between Vancomycin MIC Values and Those of Other Agents against Gram-Positive Bacteria among Patients with Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2009-12, Vol.53 (12), p.5141-5144

2009

Volltextzugriff (PDF)

Reply to "Vancomycin-induced nephrotoxicity"

Antimicrobial agents and chemotherapy, 2013-05, Vol.57 (5), p.2436-2436

2013

Volltextzugriff (PDF)

Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation

Journal of antimicrobial chemotherapy, 2007-11, Vol.60 (5), p.1038-1044

2007

Volltextzugriff (PDF)

Response to the Letter to the Editor Regarding "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Response to Letter]

International journal of chronic obstructive pulmonary disease, 2021, Vol.16, p.1227-1229

2021

Volltextzugriff (PDF)

Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia

Clinical infectious diseases, 2003-06, Vol.36 (11), p.1418-1423

2003

Volltextzugriff (PDF)

Identification of optimal renal dosage adjustments for high-dose extended-infusion cefepime dosing regimens in hospitalized patients

Journal of antimicrobial chemotherapy, 2015-03, Vol.70 (3), p.877-881

2015

Volltextzugriff (PDF)

Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.2889-2900

2020

Volltextzugriff (PDF)

Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A pilot study

Diagnostic microbiology and infectious disease, 2017-07, Vol.88 (3), p.259-263

2017

Volltextzugriff (PDF)

Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin

Journal of antimicrobial chemotherapy, 2014-09, Vol.69 (9), p.2547-2555

2014

Volltextzugriff (PDF)

Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients

Clinical infectious diseases, 2009-08, Vol.49 (4), p.507-514

2009

Volltextzugriff (PDF)

Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin-Resistant Enterococcus in a Level 1 Trauma Center

Clinical infectious diseases, 2002-04, Vol.34 (7), p.922-929

2002

Volltextzugriff (PDF)

Vancomycin: We Can't Get There From Here

Clinical infectious diseases, 2011-04, Vol.52 (8), p.969-974

2011

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Englisch
(274)
Japanisch
(30)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(204)
Life Sciences & Biomedicine
(201)
Humans
(147)
Microbiology
(129)
Pharmacology & Pharmacy
(125)
Infectious Diseases
(107)
Female
(79)
Male
(75)
Adult
(69)
Biological And Medical Sciences
(68)
Medical Sciences
(67)
Anti-Bacterial Agents - Therapeutic Use
(66)
Middle Aged
(65)
Pharmacology. Drug Treatments
(57)
Antibiotics
(55)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(52)
Aged
(44)
Microbial Sensitivity Tests
(43)
Vancomycin
(41)
Anti-Bacterial Agents - Pharmacokinetics
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy

Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections

Meropenem Penetration into Epithelial Lining Fluid in Mice and Humans and Delineation of Exposure Targets

Identification of Optimal Renal Dosage Adjustments for Traditional and Extended-Infusion Piperacillin-Tazobactam Dosing Regimens in Hospitalized Patients

Telavancin Pharmacokinetics and Pharmacodynamics in Patients with Complicated Skin and Skin Structure Infections and Various Degrees of Renal Function

A Systematic Review of the Methods Used to Assess the Association between Appropriate Antibiotic Therapy and Mortality in Bacteremic Patients

Comparative Evaluation of Serotonin Toxicity among Veterans Affairs Patients Receiving Linezolid and Vancomycin

Correlation between Vancomycin MIC Values and Those of Other Agents against Gram-Positive Bacteria among Patients with Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus

Reply to "Vancomycin-induced nephrotoxicity"

Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation

Response to the Letter to the Editor Regarding "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Response to Letter]

Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia

Identification of optimal renal dosage adjustments for high-dose extended-infusion cefepime dosing regimens in hospitalized patients

Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies

Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A pilot study

Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin

Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients

Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin-Resistant Enterococcus in a Level 1 Trauma Center

Vancomycin: We Can't Get There From Here

Suchergebnisse filtern